Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729686 · ClinicalTrials.gov registry record · Phase 4
The Pericapsular Nerve Block in Total Hip Arthroplasty
A Phase 4 study of Hip Osteoarthritis and Hip Arthropathy, sponsored by LifeBridge Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT04729686: Recruiting Phase 4 study of Hip Osteoarthritis and Hip Arthropathy, sponsored by LifeBridge Health.
NCT04729686 is a Phase 4 study of Hip Osteoarthritis and Hip Arthropathy that is actively recruiting participants, run by LifeBridge Health. The registered enrollment target is 78 participants, below the 398-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04729686, a Phase 4 study of Hip Osteoarthritis and Hip Arthropathy, is actively recruiting participants, sponsored by LifeBridge Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.
Primary Outcome
Score recorded by drawing a vertical line on a 100 mm horizontal line between "No Pain" (0 mm) and "Worst Pain" (100 mm)
Conditions Studied
Interventions
- DRUG Pericapsular Nerve Block
- DRUG Fascia Iliaca Nerve Block
Study Locations (1)
Maryland
- Sinai Hospital of Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 4 |
What NCT04729686 shows while recruiting
NCT04729686 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 398-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Hip Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Pericapsular Nerve Block is the first listed.
NCT04729686 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04729686 about?
NCT04729686 is a clinical study titled "The Pericapsular Nerve Block in Total Hip Arthroplasty". In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fasc...
What is the current status of trial NCT04729686?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2020-12-09. Estimated completion is 2025-12-01.
What conditions does trial NCT04729686 study?
This clinical trial studies the following conditions: Hip Osteoarthritis, Hip Arthropathy.
What interventions are being tested in trial NCT04729686?
The interventions under investigation include: Pericapsular Nerve Block (DRUG), Fascia Iliaca Nerve Block (DRUG).
Who is sponsoring clinical trial NCT04729686?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04729686 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04729686's enrollment target sits among peer trials
78 10th of 11 higher than 2 of 11 other Hip Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain
RECRUITING · Phase 4
-
Restoration Anatomic Acetabular Shell Revision Study
RECRUITING · NA
-
General vs Spinal in Total Joint Arthroplasty (TJA)
RECRUITING · NA
-
Return to Golf After Orthopaedic Surgery
RECRUITING
-
Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness
RECRUITING · NA
-
Influence of Antiseptic Washes on Wound Healing Complications After THA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI